The phytoestrogen genistein affects inflammatory-related genes expression depending on the ER?/ER? ratio in breast cancer cells

被引:30
作者
Gabriel Pons, Daniel [1 ,2 ]
Vilanova-Llompart, Joana [1 ]
Gaya-Bover, Auba [1 ,2 ]
Alorda-Clara, Marina [1 ,2 ]
Oliver, Jordi [1 ,2 ,3 ]
Roca, Pilar [1 ,2 ,3 ]
Sastre-Serra, Jorge [1 ,2 ,3 ]
机构
[1] Univ Illes Balears, Univ Invest Ciencies Salut IUNICS, Oncol Traslac Inst, Grp Multidisciplinar, Palma De Mallorca, Spain
[2] Hosp Univ Son Espases, Inst Invest Sanitaria Islas Baleares IdISBa, Edificio S, Palma De Mallorca, Spain
[3] Inst Salud Carlos III, Ciber FisiopatolcObesidad & Nutr CB06 03, Madrid, Spain
关键词
Breast cancer; genistein; ER; ER? ratio; inflammation; sirtuin; ESTROGEN-RECEPTOR-ALPHA; NF-KAPPA-B; OXIDATIVE STRESS; MITOCHONDRIAL FUNCTIONALITY; ER-BETA; PROLIFERATION; CYTOKINES; LINES; 17-BETA-ESTRADIOL; INHIBITION;
D O I
10.1080/09637486.2019.1597025
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Breast cancer is the most common malignancy in women of developed countries. The aim of this study was to investigate the effects of the phytoestrogen genistein on the inflammatory profile in three breast cancer cell lines with different oestrogen receptors alpha (ER?) and beta (ER?) ratio. MCF-7 (high ER?/ER? ratio), T47D (low ER?/ER? ratio), and MDA-MB-231 (ER?-negative) cells were treated with 1??M of genistein for 48?h (cell proliferation and ROS production) or 4?h (mRNA expression of 18S, ER?, ER?, pS2, Sirtuin1, IL-1?, NF-?B, COX-2, TGF?1, PPAR?). Genistein caused a significant decrease in cell viability and an increase in ROS production in MCF-7, and the opposite happens in T47D cells. In addition, genistein rise pro-inflammatory and reduced anti-inflammatory genes expression in MCF-7, provoking the opposite effects in T47D cells. In conclusion, the phytoestrogen genistein could modulate the expression of inflammatory-related genes through its interaction with both ERs, and its effects depends on the ER?/ER? ratio.
引用
收藏
页码:941 / 949
页数:9
相关论文
共 53 条
  • [1] Phytoestrogens and breast cancer
    Adlercreutz, H
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 83 (1-5) : 113 - 118
  • [2] Eicosanoids in inflammation and cancer: the role of COX-2
    Agarwal, Smita
    Reddy, Gorla Venkateswara
    Reddanna, Pallu
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (02) : 145 - 165
  • [3] [Anonymous], INT J EVOL BIOL
  • [4] Crosstalk of TGF-β and Estrogen Receptor Signaling in Breast Cancer
    Band, Arja M.
    Laiho, Marikki
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2011, 16 (02) : 109 - 115
  • [5] Muscle GLUT4 regulation by estrogen receptors ERβ and ERα
    Barros, RPA
    Machado, UF
    Warner, M
    Gustafsson, JÅ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1605 - 1608
  • [6] Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)γ agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1β-stimulated rat chondrocytes:: evidence for PPARγ-independent inhibition by 15-deoxy-Δ12,14prostaglandin J2
    Bianchi, A
    Moulin, D
    Sebillaud, S
    Koufany, M
    Galteau, MM
    Netter, P
    Terlain, B
    Jouzeau, JY
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (06) : R1325 - R1337
  • [7] Quantification of estrogen receptor α and β expression in sporadic breast cancer
    Bièche, I
    Parfait, B
    Laurendeau, I
    Girault, I
    Vidaud, M
    Lidereau, R
    [J]. ONCOGENE, 2001, 20 (56) : 8109 - 8115
  • [8] Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer
    Bierie, Brian
    Chung, Christine H.
    Parker, Joel S.
    Stover, Daniel G.
    Cheng, Nikki
    Chytil, Anna
    Aakre, Mary
    Shyr, Yu
    Moses, Harold L.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (06) : 1571 - 1582
  • [9] Bouker KB, 2000, ENVIRON HEALTH PERSP, V108, P701, DOI 10.2307/3434722
  • [10] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867